Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sean X. Yan"'
Autor:
Tiffany Tang, Peter Martin, Nagavalli Somasundaram, Cindy Lim, Miriam Tao, Eileen Poon, Maica JD. Yunon, Shu Q. Toh, Sean X Yan, Mohamad Farid, Jason Y. Chan, Soon T. Lim
Publikováno v:
Haematologica, Vol 106, Iss 12 (2020)
Selinexor is a selective inhibitor of nuclear export with anti-cancer properties. We performed a phase I study to determine the safety and maximum tolerated dose of selinexor when combined with high-dose dexamethasone, ifosfamide, carboplatin and eto
Externí odkaz:
https://doaj.org/article/6c1ddc15724a4725a245f1bd03b47d40
Autor:
Eileen Poon, Miriam Tao, Nagavalli Somasundaram, Jason Yongsheng Chan, Peter Martin, Maica Jd Yunon, Shu Q Toh, Cindy Lim, Mohamad Farid, Soon T Lim, Tiffany Tang, Sean X Yan
Publikováno v:
Haematologica
Selinexor is a selective inhibitor of nuclear export with anti-cancer properties. We performed a phase I study to determine the safety and maximum tolerated dose of selinexor when combined with high-dose dexamethasone, ifosfamide, carboplatin and eto
Autor:
Jen San Wong, Richard Hoau Gong Lo, M Wang, Sean X. Yan, F.G. Irani, Sue Ping Thang, David Tai, Brian K. P. Goh, Choon Hua Thng, David Chee Eng Ng, Kiat Hon Lim, Kelvin Siu Hoong Loke, Apoorva Gogna, Anthony S. W. Goh, Chow Wei Too, Kiang Hiong Tay, Pierce K. H. Chow, Su Pin Choo, Sum Leong, Han Chong Toh
Publikováno v:
Liver Cancer. 5:97-106
Hepatocellular carcinoma (HCC) is the 6th most common cancer in the world, but the second most common cause of cancer death. There is no universally accepted consensus practice guidelines for HCC owing to rapid developments in new treatment modalitie